Loading stock data…
cbdMD, Inc. (YCBD)
$0.70+0.00 (+0.70%)
After Hours$0.70+0.00 (+0.00%)· Last close Jun 29
cbdMD, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
cbdMD, Inc. in the Healthcare sector is trading at $0.70 with a market capitalization of $7M. Wall Street consensus targets $2.00 (1 analysts), implying a +185.7% move over the next 12 months. The stock is currently near its 52-week low of $0.47, remaining 19.5% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +185.7% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $5.64M↑ | $5.02M↑ | $4.72M↑ | $4.61M↓ | $4.75M |
| Gross Profit | $3.26M↑ | $3.00M↑ | $2.78M↓ | $2.83M↓ | $2.96M |
| Operating Income | -$800,784↓ | -$286,288↑ | -$685,816↑ | -$904,686↓ | -$485,816 |
| Net Income | -$797,978↓ | -$283,131↑ | -$679,968↑ | -$895,272↓ | -$480,757 |
Peer Comparison
JNJUNHPFE
Fundamentals
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gel...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$7.35M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
0.28
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-28.61%
Volume
Today's trading volume
253,494
Recent News
Why cbdMD Inc (YCBD)’s Management is Optimistic After March Quarter Results
cbdMD Inc (NYSEAMERICAN:YCBD) is one of the best CBD stocks to buy right now. The stock has gained around 35% over the past six months, and analysts see more upside potential, expecting the stock to surge more than 160% over the next 12 months. cbdMD Inc (NYSEAMERICAN:YCBD) reported its March quarter results on May 14. […]
cbdMD Inc (YCBD) Q2 2026 Earnings Call Highlights: Strong Sales Growth Amidst Regulatory Challenges
cbdMD Inc (YCBD) reports a 19% increase in net sales and strategic investments, while navigating cost pressures and regulatory hurdles.
cbdMD, Inc. Q3 2026 Earnings Call Summary
Moby summary of cbdMD, Inc.'s Q3 2026 earnings call
cbdMD, Inc. Q1 2026 Earnings Call Summary
Moby summary of cbdMD, Inc.'s Q1 2026 earnings call
cbdMD Inc (YCBD) Q1 2026 Earnings Call Highlights: Strategic Acquisitions and Financial ...
cbdMD Inc (YCBD) reports significant financial management improvements and strategic acquisitions, despite facing sales and regulatory challenges.